Previous data indicate that the increased KATP channel membrane expression in mice transgenically expressing a peptide inhibitor of CaMKII (AC3-I), or increased KATP channel current induced by KATP channel openers, correlates with reduced myocardial infarction size following ischemia/reperfusion [28]. The gene discussed is CAMK2G; the disease is ischemia.